Titre
Association Between Patient Sex and Familial Hypercholesterolemia and Long-Term Cardiovascular Risk Factor Management 5 Years After Acute Coronary Syndrome.
Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Auteur(s)
Krasieva, K.
Auteure/Auteur
Gencer, B.
Auteure/Auteur
Locatelli, I.
Auteure/Auteur
Carballo, D.
Auteure/Auteur
Muller, O.
Auteure/Auteur
Fournier, S.
Auteure/Auteur
Matter, C.M.
Auteure/Auteur
Räber, L.
Auteure/Auteur
Rodondi, N.
Auteure/Auteur
Mach, F.
Auteure/Auteur
Nanchen, D.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1941-7705
Statut éditorial
Publié
Date de publication
2024-08
Volume
17
Numéro
8
Première page
e010790
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article ; Multicenter Study ; Comparative Study ; Observational Study
Publication Status: ppublish
Publication Status: ppublish
Résumé
Long-term control of cardiovascular risk factors after acute coronary syndrome (ACS) is the cornerstone for preventing recurrence. We investigated the extent of cardiovascular risk factor management in males and females with and without familial hypercholesterolemia (FH) 5 years after ACS.
We studied patients hospitalized for ACS between 2009 and 2017 in a Swiss multicenter prospective cohort study. FH was defined based on clinical criteria from the Dutch Lipid Clinic Network and Simon Broome definitions. Five years post-ACS, we assessed low-density lipoprotein-cholesterol (LDL-c) levels, lipid-lowering therapy (LLT), and other cardiovascular risk factors, comparing males to females with and without FH using generalized estimating equations.
A total of 3139 patients were included; mean age was 61.4 years (SD, 12.1), 620 (19.8%) were female, and 747 (23.5%) had possible FH. Compared with males at 5-years post-ACS, females were more likely to not use statins (odds ratio, 1.61 [95% CI, 1.28-2.03]) and less likely to have combination LLT (odds ratio, 0.72 [95% CI, 0.55-0.93]), without difference between patients with FH and without FH. Females in both FH and non-FH groups less frequently reached LDL-c values ≤1.8 mmol/L (odds ratio, 0.78 [95% CI, 0.78-0.93]). Overall, patients with FH were more frequently on high-dose statins compared with patients without FH (51.0% versus 42.9%; P=0.001) and presented more frequently with a combination of 2 or more LLT compared with patients without FH (33.8% versus 17.7%; P<0.001), but less frequently reached LDL-c targets of ≤1.8 mmol/L (33.5% versus 44.3%; P<0.001) or ≤2.6 mmol/L (70.2% versus 78.1%; P=0.001).
Five years after ACS, females had less intensive LLT and were less likely to reach target LDL-c levels than males, regardless of FH status. Males and females with FH had less optimal control of LDL-c despite more frequently taking high-dose statins or combination LLT compared with patients without FH. Long-term management of patients with ACS and FH, especially females, warrants optimization.
We studied patients hospitalized for ACS between 2009 and 2017 in a Swiss multicenter prospective cohort study. FH was defined based on clinical criteria from the Dutch Lipid Clinic Network and Simon Broome definitions. Five years post-ACS, we assessed low-density lipoprotein-cholesterol (LDL-c) levels, lipid-lowering therapy (LLT), and other cardiovascular risk factors, comparing males to females with and without FH using generalized estimating equations.
A total of 3139 patients were included; mean age was 61.4 years (SD, 12.1), 620 (19.8%) were female, and 747 (23.5%) had possible FH. Compared with males at 5-years post-ACS, females were more likely to not use statins (odds ratio, 1.61 [95% CI, 1.28-2.03]) and less likely to have combination LLT (odds ratio, 0.72 [95% CI, 0.55-0.93]), without difference between patients with FH and without FH. Females in both FH and non-FH groups less frequently reached LDL-c values ≤1.8 mmol/L (odds ratio, 0.78 [95% CI, 0.78-0.93]). Overall, patients with FH were more frequently on high-dose statins compared with patients without FH (51.0% versus 42.9%; P=0.001) and presented more frequently with a combination of 2 or more LLT compared with patients without FH (33.8% versus 17.7%; P<0.001), but less frequently reached LDL-c targets of ≤1.8 mmol/L (33.5% versus 44.3%; P<0.001) or ≤2.6 mmol/L (70.2% versus 78.1%; P=0.001).
Five years after ACS, females had less intensive LLT and were less likely to reach target LDL-c levels than males, regardless of FH status. Males and females with FH had less optimal control of LDL-c despite more frequently taking high-dose statins or combination LLT compared with patients without FH. Long-term management of patients with ACS and FH, especially females, warrants optimization.
Sujets
PID Serval
serval:BIB_32B0D5479156
PMID
Open Access
Oui
Date de création
2024-06-24T06:56:35.654Z
Date de création dans IRIS
2025-05-20T16:50:13Z
Fichier(s)![Vignette d'image]()
![Vignette d'image]()
![Vignette d'image]()
En cours de chargement...
Nom
Thèse MD final.pdf
Version du manuscrit
published
Taille
614.13 KB
Format
Adobe PDF
PID Serval
serval:BIB_32B0D5479156.P002
URN
urn:nbn:ch:serval-BIB_32B0D54791566
Somme de contrôle
(MD5):d53caeac327a381282c5f709c9e1f44c
En cours de chargement...
Nom
Imprimatur.pdf
Version du manuscrit
supplementary
Taille
172.86 KB
Format
Adobe PDF
PID Serval
serval:BIB_32B0D5479156.S001
Somme de contrôle
(MD5):91cf25a36b1108f8072efe7ad8bfcbaa
En cours de chargement...
Nom
circcvqo_circcqo-2023-010790d_supp1.pdf
Version du manuscrit
supplementary
Taille
637.67 KB
Format
Adobe PDF
PID Serval
serval:BIB_32B0D5479156.S002
Somme de contrôle
(MD5):491bd145544f44c09d0246aeb03cd241